- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- June 2025
- 400 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- January 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- July 2023
- 145 Pages
Global
From €2751EUR$3,150USD£2,390GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- December 2023
- 300 Pages
Global
From €1092EUR$1,250USD£948GBP
€2183EUR$2,500USD£1,897GBP
- Report
- December 2023
- 80 Pages
Russia
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- December 2023
- 80 Pages
Poland
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 100 Pages
Africa
From €873EUR$1,000USD£759GBP
€1747EUR$2,000USD£1,517GBP
- Report
- October 2023
- 300 Pages
Global
From €1092EUR$1,250USD£948GBP
€2183EUR$2,500USD£1,897GBP
- Report
- October 2023
- 80 Pages
France
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
South Korea
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
United States
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
India
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 80 Pages
Germany
From €655EUR$750USD£569GBP
€1310EUR$1,500USD£1,138GBP

Liothyronine is a synthetic form of the thyroid hormone triiodothyronine (T3). It is used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is also used to treat goiter, an enlarged thyroid gland, and to treat thyroid cancer. Liothyronine is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Liothyronine is available in both brand-name and generic forms. It is available as a tablet, capsule, and liquid solution. It is usually taken once a day, but the dosage and frequency may vary depending on the patient's condition.
Companies in the Liothyronine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more